Introduction consensus site [CAC (C/G) (T/G) (G/T)]
. This sequence has sufficient wobble such that it includes a subset of E Transcriptional repression plays a crucial role in determinboxes (CANNTG). Indeed, ZEB has been shown to bind ing patterns of tissue-specific gene expression during E boxes with the sequence CACCTG, but not other E development, although the precise mechanisms are poorly boxes . Additionally, as the consensus understood in most cases (Johnson, 1995; Gray and Levine, sequence indicates, ZEB binds to other sites that are not 1996b). A number of transcriptional repressors contain E boxes . The N-and C-terminal zinc finger and homeodomain motifs (Gray and Levine, zinc fingers of ZEB serve as DNA binding domains and 1996b). For example, the Drosophila zinc finger protein appear to have similar affinity and binding specificity Krüppel represses the even-skipped stripe 2 enhancer, . Although it has been found that which is important in segmentation (Stanojevic et al., ZEB can compete with the basic helix-loop-helix (bHLH) 1991), and Drosophila Snail represses rhomboid expression in the mesoderm, which seems to be important in protein E2.5 for binding to the μE5 E box in the Ig heavy chain gene enhancer (Genetta et al., ), no 1993 . The vertebrate homolog of Zfh-1, ZEB, is also transcriptional activity of ZEB was demonstrated (Genetta expressed in muscle precursors, in the undifferentiated et al., 1994) . Previous studies have found that some E somite and in the dermatomyotome (Funahashi et al., box-like sequences can negatively regulate genes (Simon 1993) , suggesting a role for ZEB in vertebrate myogenesis. and Burden, 1993; Weintraub et al., 1994; Desbarats et al., In support of this possibility, we found that a number of 1996; Duncan et al., 1996) , but it is not known whether muscle-restricted genes contain ZEB consensus binding these sites bind ZEB or the mechanism through which sequences [i.e. the bHLH MRF genes (Edmondson et al., they regulate gene expression.
1992; Tapscott et al., 1992; Black et al., 1995) , muscle ZEB appears identical to the chicken δEF1 protein, creatine kinase (MCK) (Amacher et al., 1993) and the overexpression of which inhibits myoD-induced expresacetylcholine receptor δ subunit (Simon and Burden, sion of some muscle genes (e.g. troponin T) in 10T1/2 1993)]. Indeed, ZEB has been shown to interact with the cells (Sekido et al., 1994) . Indeed, we have found that a MEF-1 site in the MCK gene ; Sekido number of muscle-restricted genes contain ZEB consensus et al., 1994) . Moreover, ZEB appears identical to the sites in their promoter regions (see below). Moreover, like chicken protein δEF1, which has been shown to block Zfh-1, ZEB is expressed in muscle cell precursors: it is myoD-induced expression of muscle genes such as found in the epithelium of the undifferentiated somite and troponin T in 10T1/2 cells (Sekido et al., 1994) , further the dermomyotome preceding myogenic differentiation in suggesting a role for ZEB in vertebrate myogenesis. embryonic mice . Therefore, ZEB To demonstrate that ZEB has a role in regulating muscle is present before active myogenic regulatory factors differentiation we used the differentiation of C2C12 myo-(MRFs) appear and is expressed in the proper spatial and blasts into myotubes as a myogenic assay (Rosen et al., temporal pattern to regulate muscle genes in undifferenti-1992) . Stable expression of ZEB in C2C12 cells blocked ated cells. All these results together further suggest a role myotube formation and expression of differentiationfor ZEB during muscle differentiation.
specific markers such as myosin heavy chain, myogenin Muscle differentiation is regulated by two families of and α4 integrin ( Figure 1A -J and data not shown), positive factors: (i) the MRF family of bHLH proteins providing further evidence for ZEB as a negative regulator (myoD, myf-5, myogenin and MRF-4) that induce muscle of myogenesis. differentiation by binding E box sequences in the reguLikewise, myotube formation and expression of latory regions of muscle genes activating their transcripdifferentiation markers such as myosin heavy chain by tion; (ii) the MEF-2 proteins, which synergize with MRF overexpression of myoD into 10T1/2 cells (Thayer and proteins to regulate muscle differentiation and activate ) was inhibited by co-transfection of an transcription either by binding to specific DNA sequences expression vector for ZEB (Figure 2A and B). or by interaction with the MRF proteins (Molkentin Since recombinant ZEB can compete with recombinant et al., 1995) . Initially, it was assumed that myogenic E2.5 for binding to the μE5 E box in vitro (Genetta et al. , differentiation was dependent only on the activity of 1994), we presumed that ZEB may inhibit myogenesis by MRF and MEF-2 proteins (and their synergistic activity), displacing MRF proteins from E boxes as suggested however, recent evidence indicates that muscle differenti- Sekido et al., 1994) . To test this ation is also under negative regulation and that a proper hypothesis, we examined the activity of a ZEB construct temporal and spatial pattern of muscle gene expression is expressing only the DNA binding domain of ZEB (DBthe result of a fine balance between positive and negative ZEB) in the myogenic assay (Figure 2A and B). We factors (Benezra et al., 1990; Chen et al., 1996; Spicer reasoned that if ZEB functions simply by displacing MRF et al., 1996) . Negative regulators of myogenesis, such as proteins from E boxes, then the DNA binding domain Twist, members of the Id family and I-mfa, all act by should be sufficient for full activity. DB-ZEB bound to binding MRF and/or MEF-2 proteins and blocking their ZEB sites with greater affinity than the full-length protein activity (Benezra et al., 1989; Chen et al., 1996; Spicer and it displaced myoD from CACCTG sequences more et al., 1996) , however, we show here that ZEB inhibits efficiently than ZEB (data not shown). However, surprismuscle differentiation through a unique mechanism that ingly, DB-ZEB had little effect on myogenic differentiation involves interaction with the promoter of muscle genes compared with full-length ZEB (Figure 2A and B). Many and active repression of transcription. We mapped the muscle genes contain multiple E boxes and the ZEB region in ZEB needed for such repression and we show that binding sequence CACCTG only constitutes a small subset ZEB is able to block transcriptional activation mediated by of these E boxes. Our results with DB-ZEB indicate that MEF-2 as well as the synergism between MRF and displacing MRF proteins from these CACCTG sites is not MEF-2, which is thought to be important for myogenic sufficient to block myogenic differentiation (i.e. binding differentiation (Molkentin et al., 1995 (Molkentin et al., , 1996 Lilly et al., of MRF proteins to the other non-CACCTG E boxes 1995; Olson et al., 1995) . Finally, we suggest a mechanism appears to be sufficient to induce differentiation). Instead, whereby ZEB can regulate the temporal pattern of muscle we concluded that full-length ZEB is likely to be an active gene expression during development.
transcription factor when it is bound to CACCTG and to other non-E box sequences and that this activity of the
Results
full-length protein is required for inhibition of myogenic differentiation. We demonstrate below that ZEB is indeed ZEB is a negative regulator of muscle an active transcriptional repressor and that its interaction differentiation with E boxes is not a mechanism for displacement of Zfh-1 in Drosophila is expressed in muscle precursors and is required for proper muscle formation (Lai et al., MRF proteins, but instead is an important regulatory Immunofluorescent staining for α4 (B, E and H) and myosin heavy chain (C, F and I), which are expressed during myogenic differentiation, is shown at higher magnification. Transfected ZEB mRNA was detected by Northern blot (J) using an oligonucleotide encoding a HA-tag located at the 5Ј-end of ZEB cDNA; total ZEB mRNA was detected by reprobing the blot with an NdeI-HindIII fragment of ZEB cDNA.
feature that allows MRF proteins to displace ZEB and MCK (the MEF-1 site; Amacher et al., 1993) and the acetylcholine receptor δ subunit (the E1 box; Simon and derepress transcription during myogenic differentiation.
Burden, 1993), showed similar silencer activity ( Figure  3B ). In addition, non-E box ZEB sites (Genetta et al., ZEB blocks muscle differentiation by active transcriptional repression 1994; Sekido et al., 1994) were also effective repressors of -76CAT (results not shown). Gel retardation assays As a first step in analyzing the transcriptional activity of ZEB, we examined the activity of ZEB sites present in with the -361 and -399 sites indicated that they do indeed bind ZEB ( Figure 3C ). The ubiquitous bHLH activating the promoters of different genes expressed in muscle. One such gene that contains consensus ZEB sites is α4 integrin, protein USF (Sawadogo and Roeder, 1985) also binds these sites, however, the ZEB sites only bind weakly to whose expression is activated during muscle differentiation . Previously we found that interaction USF and overexpression of USF did not activate or repress transcription through the ZEB sites (results not shown). between α4 integrins and their ligand VCAM-1 is important in myogenic differentiation and that α4 expression is Expression of DB-ZEB blocked silencer activity of the ZEB sites in myoblasts by displacing endogenous ZEB induced during differentiation of C2C12 cells . Expression of the α4 gene is dependent ( Figure 3B ) and, accordingly, it restored α4 gene promoter activity in myoblasts (results not shown). Therefore, DBupon constitutively active Ets sites in the first 76 bp of the promoter . Transfection of α4 ZEB appears to act efficiently as a dominant negative that blocks repression by ZEB. Together, the above results gene promoter constructs into the α4(-) C2C12 myoblast cell line revealed that the gene is under negative regulation suggest that ZEB is an active transcriptional repressor and that this repressor activity is important for its negative that inhibits the activity of these Ets sites in undifferentiated cells ( Figure 3A ). Silencer activity is dependent upon role in myogenesis.
To demonstrate directly that ZEB is an active transcriptwo consensus ZEB sites (CACCTG) at -361 and -399. Consensus ZEB sites from other muscle genes, such as tional repressor, it was fused to the DNA binding domain of the yeast transcription factor Gal4 ( Figure 4A ). Gal4-differentiation of C2C12 cells into myotubes (results not shown) nor does its level decrease following muscle ZEB efficiently inhibited transcriptional activation by the α4 gene Ets sites as well as a number of other transcription differentiation in the mouse . Therefore, it was unclear how repressor activity is lost factors (including the SV40 enhancer) ( Figure 4B and results not shown). Neither the N-nor C-terminal zinc during myogenesis. Since this loss of repressor activity occurs as active MRF proteins appear, we reasoned that finger DNA binding domains were required for repressor activity, as suggested above. In contrast, the central the MRF proteins may block ZEB activity. Indeed, forced expression of either myoD or myf-5 in undifferentiated region containing the homeodomain showed full repressor activity. However, the homeodomain itself was not cells released repression ( Figure 5A ). These results suggest that MRF proteins may displace ZEB from CACCTG required for repressor activity, instead the repressor domain lies between the homeodomain and the N-terminal zinc sites as they accumulate during differentiation. Consistent with such a model, we found that myoD binds to CACCTG fingers. A Western blot analysis revealed that all Gal4-ZEB proteins were of the predicted size (results not sequences with greater affinity than ZEB ( Figure 5B ), implying that ZEB would be displaced from these sites shown). The degree of repression by ZEB was similar to that of retinoblastoma protein ( Figure 4B ), which we as active MRF proteins appear during myogenic differentiation. However, the affinity of ZEB and MRFs for E have demonstrated previously is a potent transcriptional repressor .
boxes is dependent upon sequences surrounding the CACCTG core, such that their relative affinity varies significantly for sites in different muscle genes (results MyoD displaces ZEB from ZEB binding sites and activates transcription in a ZEB-resistant fashion not shown). Thus, the type of site in a promoter determines the level of MRF protein required to displace ZEB and Transcriptional repression through ZEB sites is lost upon myogenic differentiation of C2C12 cells (Figures 3A and activate the muscle gene. Interestingly, we found that ZEB is unable to block 5A). However, ZEB expression does not diminish upon Figures 3-6 , empty expression vectors were co-transfected as controls and they had no effect on CAT activity. Similar results were obtained with 10T1/2 cells. (B) ZEB sites from different genes act as silencers. E boxes with ZEB consensus sequences (CACCTG) were cloned upstream of the Ets sites in -76CAT. -361 and -399 indicate E boxes in the α4 gene. MEF-1 indicates the MEF-1 site from the MCK gene and AchR the E1 box from the acetylcholine receptor δ subunit gene. For DB-ZEB overexpression, 0.2 μg pci-FLAG-DB-ZEB were co-transfected with 3 μg reporter plasmid. (C) Interaction of ZEB and MRF proteins with ZEB sites. Gel retardation assay with nuclear extract from 10T1/2 cells or 10T1/2 cells transfected with a myf-5 expression vector (identical results were obtained with a myoD expression vector). A probe containing the E361 and E399 sites was used in the assay. Competitor indicates addition to the binding assay reaction of a 50-fold excess of unlabeled E361 probe or 0.5 μg antibodies against E2, myf-5, ZEB and c-myb. ZEB* indicates supershifted complexes when using the anti-ZEB antibody in the binding reaction. myf-5/E2 indicates the binding of complexes containing myf-5 and E proteins in cells transfected with myf-5. Antibodies against both E2 and myf-5 proteins blocked the binding of such complexes. transcriptional activation by either myoD or myf-5 ( Figure  6B and C). MEF-2 is essential for myogenesis in Drosophila (Lilly et al., 1995) and it has been shown during 6A), suggesting a second mechanism by which MRF proteins can overcome transcriptional repression by ZEB. development to form an amplification loop with MRF proteins that increases the level of both MEF-2 and the This observation may be important because, as noted above, not all ZEB sites are E boxes (and non-E box ZEB MRFs . MEF-2 and MRF proteins interact such that one protein can tether the other to the sites are also effective repressor sites; results not shown) and MRF proteins would be unable to displace ZEB from promoter (Molkentin et al., 1995;  Figure 6B ). The resulting transcriptional synergy between MEF-2 and MRFs has such non-E box sites. Many muscle genes contain multiple E boxes (CANNTG), but most of these sites do not bind been shown to augment myogenic differentiation (Molkentin et al., 1995) . We found that ZEB blocks the ZEB (CACCTG). Therefore, if a muscle gene contains an E box sequence that does not bind ZEB, then MRF transcriptional synergy between myoD/E12 and MEF-2C, bringing activation down to the level of myoD/E12 alone proteins would be expected to activate transcription in a ZEB-resistant fashion through this site, even if the pro-( Figure 6B ). When MEF-2 was brought directly to the promoter as a Gal4 fusion protein, its activity was also moter also contains a ZEB site (of any type).
blocked by ZEB ( Figure 6C ), suggesting that ZEB blocks the synergy because it represses the transactivating domain ZEB blocks transactivation by MEF-2 and its synergism with MRF proteins of MEF-2. Our results then suggest that one target of negative regulation by ZEB during myogenesis may be While transcriptional activation through the MRF proteins appears resistant to ZEB, the activity of another muscle MEF-2 activation and transcriptional synergy between MEF-2 and MRF proteins. transcription factor, MEF-2, is efficiently inhibited ( Figure Fig of myogenesis and presented evidence that it functions (Neuhold and Wold, 1993) were synthesized by coupled in vitro transcription/translation. The relative concentration of the proteins through a mechanism and at a level distinct from previously were estimated by SDS-PAGE (data not shown) and the relative identified negative regulators, such as Id proteins, Twist amount of myoD/E47 is indicated above the lanes.
and I-mfa. We also provide evidence that one target of ZEB is MEF-2 and the transcriptional synergy between MEF-2 and MRF proteins, which is thought to promote or too many precursors in some muscles (Lai et al., 1993) , suggesting a role for Zfh-1 in the timing of differentiation myogenic differentiation (Molkentin et al., 1995) .
Members of the Zfh family of zinc finger/homeodomain and/or the positioning of muscle precursors when they differentiate. Although there is no information about the proteins are expressed in the central nervous system (CNS) and, in the case of Zfh-1 and -4, also in mesoderm mechanism through which Zfh-1 functions, the phenotype of zfh-1 mutants is consistent with Zfh-1 as a negative derivatives, including muscle Kostich and Sanes, 1995) . A human homolog of Drosophila Zfh-2 regulator of muscle differentiation, as we propose here for its vertebrate homolog ZEB. (ATBF-1) has been cloned and it has been shown to repress the α-fetoprotein promoter by binding to AT-rich Zfh-1 is also expressed in the CNS and overexpression of Zfh-1 in Drosophila during the embryonic, larval and areas, although the precise mechanism of repression is not understood Lundell and Hirsh, pupal periods results in high lethality and severe defects in the developing CNS, suggesting that Zfh-1 also has a 1992; Yasuda et al., 1994) . Like its Drosophila homolog Zfh-1 , ZEB is expressed in muscle regulatory role in CNS differentiation . In addition to muscle, ZEB is also expressed in the precursors and we present evidence that it regulates muscle differentiation by inhibiting muscle gene expression and developing CNS . Thus, it is reasonable to assume that ZEB may also have a role in myotube formation. Taken together, these results suggest that the Zfh family may be comprised of transcriptional regulation of CNS differentiation. Recently, several genes that negatively regulate myorepressors involved in differentiation of various tissues.
It is interesting to note that mutation of zfh-1, rather genesis have been identified, such as members of the Id family, Twist and I-mfa (Benezra et al., 1990; Chen et al. , than blocking muscle differentiation, results in multiple abnormalities with mispositioning of muscles and too few 1996; Spicer et al., 1996) . These other proteins inhibit Figure 4B were co-transfected, indicating that the Gal4 sites in the construct are functional. Also, note that the amount of Gal4-ZEB 918-2714 transfected was even greater than in Figure 4 , where it efficiently blocked transcription. Gal4-ZEB fs (see Figure 4 ) was used as a negative control in these transfections (not shown). (B) G-ZEB 918-2717 blocks transcriptional synergy between MEF-2 and myoD/E12. A reduced amount of expression vectors (0.03 μg myoD and E12 and 0.15 μg MEF-2C) was co-transfected with 1.5 μg p72-4E-5G reporter in order to observe synergy between myoD and MEF-2C. One microgram of G-ZEB 918-2717 was co-transfected. Note that expression was reduced to the level of myoD/E12 alone when G-ZEB 918-2717 was co-expressed; increasing the amount of G-ZEB 918-2717 transfected had no additional effect. Gal4-ZEB fs was used as a negative control and had not effect (results not shown). myogenesis by binding directly to myogenic factors like . We have examined ZEB activity in hematopoietic cells and found that it also functions as a myoD (and its E protein partners) or MEF-2 proteins and preventing their translocation to the nucleus or their repressor (Postigo et al., 1997) , suggesting a role for ZEB in hematopoietic cells. As in muscle, one target of such binding to DNA. However, ZEB works as a bona fide transcription factor, binding specific DNA sequences in repression is the α4 integrin gene. In addition to its role in myogenesis , α4 integrin has a the promoters of muscle genes and actively repressing transcriptional activity mediated by other factors, including well-studied role in hematopoeitic differentiation (Arroyo et al., 1996) and function (e.g. leukocyte trafficking, the MEF-2 proteins.
During muscle differentiation there is a precise temporal immune response and targeting of leukocytes to sites of inflammation; Lobb and Hemler, 1994) . These results pattern of gene expression, such that some genes appear early (e.g. myf-5 and myoD), others are intermediate (e.g. suggest a key role for ZEB in regulating gene expression in different tissues. myogenin) and some appear late in myogenesis (e.g. acetylcholine receptor). The precise molecular mechanism that accounts for this temporal order is not understood
Materials and methods
and simple activation of transcription by MRF and MEF-2 proteins may not be sufficient to explain the entire pattern Cell culture C2C12 and CH3-10T1/2 cells were obtained from the American Tissue Molkentin and Olson, 1996) . We Culture Collection (ATCC) and maintained in Dulbecco's modified found that E boxes from different genes vary significantly the level of active MRF proteins accumulates during For differentiation of C2C12 myoblasts to myotubes, cells were changed to DMEM with 2% horse serum (Life Technologies) as described (Rosen myogenesis, ZEB would be displaced from some genes et al., 1992) and maintained for 4 days, by which time Ͼ90% of cells at low concentrations of MRF proteins (early myogenesis), had fused into myotubes. whereas higher levels of MRF (late myogenesis) would be needed to displace ZEB from other genes. Therefore,
Plasmid construction
the interplay between ZEB and MRF proteins on different DB-ZEB was created by PCR amplification of the region of ZEB cDNA encoding the DNA binding domain (2740-3136)  genes may be a mechanism for imposing temporal order . Full-length and DB-ZEB were cloned into the on expression on some muscle genes.
MluI (5Ј) and XbaI sites of the pCI neo expression vector (Promega ZEB was first identified in B cells as a protein that Corp., Madison, WI) . Annealed oligonucleotides containing an in-frame binds in vitro to the IgH enhancer, however, no direct ATG and a Flag antibody recognition sequence were cloned upstream of the ZEB cDNA sequence into the MluI and XhoI sites. Additionally, evidence for a repressor role for ZEB was reported annealed oligonucleotides containing an SV40 nuclear localization signal 2% horse serum and cells were maintained for 4 days before harvesting for analysis of CAT activity . and an in-frame stop codon were cloned immediately downstream of the cDNA sequence into XbaI and NotI sites.
Fragments of the α4 gene promoter were obtained by PCR with In vitro transcription/translation primers containing KpnI (5Ј) and ApaI (3Ј) sites .
For transcription/translation assays, the XhoI-NotI fragment containing The products were digested with KpnI and ApaI and cloned into the the pci-flag-ZEB and pci-flag DB-ZEB cDNAs were cloned into the corresponding sites upstream of the Ets sites in -76CAT (Rosen et al., corresponding sites in pBluescript-KS (Stratagene, La Jolla, CA). MyoD-1994) . For E box constructs, annealed oligonucleotides containing the E47 (Neuhold and Wold, 1993) and the ZEB proteins were synthesized indicated E box(es) along with either 3 or 10 bp of flanking sequence in vitro using the Promega TNT kit and T3 RNA polymerase (Weintraub (results were identical with both) and containing KpnI and ApaI sites et al., 1995) . were cloned into the corresponding sites upstream of the Ets sites in -76CAT. In E361M the CACCTG core was mutated to TTGGCC or TTCCCC and in E399 to ACGCCT or ACCCCA, which blocked
